Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited, commonly referred to as Weigao, is a leading player in the medical device industry, headquartered in Shandong, China. Established in 1988, the company has grown significantly, expanding its operations across various regions, including Asia, Europe, and North America. Weigao specialises in the development and manufacturing of high-quality medical polymer products, including intravenous (IV) products, surgical instruments, and diagnostic devices. Their commitment to innovation and quality has positioned them as a trusted supplier in the healthcare sector. Notably, Weigao has achieved several milestones, including numerous certifications and awards that underscore its dedication to excellence and safety in medical technology. With a strong market presence, Weigao continues to enhance patient care through its advanced medical solutions.
DitchCarbon Score
How does Shandong Weigao Group Medical Polymer Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shandong Weigao Group Medical Polymer Company Limited's score of 19 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shandong Weigao Group Medical Polymer Company Limited's reported carbon emissions
In 2024, Shandong Weigao Group Medical Polymer Company Limited reported total emissions of approximately 126,139,020 kg CO2e, which includes 41,295,430 kg CO2e from purchased steam and 81,747,340 kg CO2e from purchased electricity, categorised under Scope 2 emissions. The company has not disclosed any Scope 1 or Scope 3 emissions data. Despite the significant emissions reported, there are currently no specific reduction targets or climate pledges outlined by the company. This lack of formal commitments may reflect a broader industry context where many organisations are still developing comprehensive climate strategies. The company’s emission intensity for 2023 was reported at approximately 26,520 kg CO2e per tonne, indicating a focus on monitoring emissions relative to revenue. However, without established reduction initiatives or targets, the path towards meaningful climate action remains unclear. Overall, while Shandong Weigao Group has provided emissions data, the absence of reduction commitments suggests an opportunity for the company to enhance its climate strategy in alignment with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | - |
| Scope 2 | 123,042,770 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shandong Weigao Group Medical Polymer Company Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
